Connect with us

Motherhood

Expert insight: A NHS midwife reviews the Ardo Melia wearable breast pump

By an NHS midwife

Published

on

I was fortunate to have the amazing opportunity to be gifted the new Ardo Melia double breast pump in return for an honest review of the product.

As a midwife I am aware of the multiple brands available and how confusing it can be to know which product to go for and more importantly that everyone is different in terms of what works for them.

I know this all too well as I am now on my 2nd breastfeeding/pumping journey with my second child.

My first breastfeeding journey was not plain sailing as I found a lot of products didn’t work for me as I was faced with many barriers from struggling to find a good fit for my breasts, to being unable to pump a consistent good milk output without causing pain and discomfort.

For this reason, I was determined to find something this time that worked for me that made pumping easier being a busy mum of two.

Therefore, when Ardo was willing to give me this opportunity, I was very eager to try one of their products due to their good reputation.

However, my review is not influenced in any way by this and is my honest and personal opinion on my experience using the pump.

First Impressions

The delivery of the product was amazing as I received it the following day which I believe is important considering how essential these products are to the user.

One of my initial discoveries when opening the box is that it was well packaged and there were the nipple sizing cut outs are on the inside of the box itself which is a genius idea, making it easier to find the right size for you (as this is not something that I have found to be provided with alternative products).

You immediately get a sense that they care about the consumer and want you to get the most out of the product.

Out of all the pumps I’ve used this is the first one I’ve come across with this included as most others require you to source this yourself.

I personally didn’t require it as I already did know my size and had ordered the inserts to use alongside the pump but its good tool for someone who might be struggling.

Another massive bonus is you get a double pump as standard, meaning you don’t need to purchase two pumps separately.

The product itself is very compact, lightweight and attractive looking, with the parts being very high quality and very easy to put together.

Everything you need comes with the pumps including bra extenders which I found very useful and was a nice touch.

The pumps do come with 24mm breast shields and 19mm inserts which again is excellent to receive as standard, my only suggestion would be to include an option for the consumer to be able to choose the size insert at purchase rather than just receiving the 19mm, as for some people like me, an additional set would need to be purchased for it to be useful.

Using the pump

The pump is very easy to use and has a good variety of settings for you to find a mode that works for you.

I found I did have a few teething issues with getting the pump to work for me but the customer service team are absolutely fantastic, providing me with lots of support and guidance which allowed me to get the most out of the pump and did rectify the issues I was having.

It also made me more aware of how much the environmental elements and stress levels can contribute to the success of a pumping session regardless of equipment.

My historical experiences of wearable breast pumps in particular was very poor, and I gave up with them during my 1st journey, but much to my surprise the Melia has been a game changer for me.

They are relatively easy to put together and use, with the hardest aspect being to ensure your nipple is centred correctly, but once you have used a few times this soon becomes second nature.

The seal is excellent, and I have had no issues at all with leaking during use, even when doing light housework which gives you the ability to be mobile whilst pumping if required.

Whilst wearing them they are so comfortable thanks to the silicone shield which fit my breast more naturally, and I feel this added to the overall comfort during the pumping session, to the point where at time I couldn’t even tell they were on in some instances.

The vacuum power is powerful but also so gentle at the same time further adding to the comfort level.

The pump is also very customisable to the user allowing you up to 15 adjustable vacuum levels; having this function allowed me to easily find a level that was comfortable and most effective for me.

The pumps LED display is very user friendly giving you useful information including the mode and how long you have been pumping.

The buttons are located at the top of the pump making it very easy to switch and change modes as required.

The pump does have a 20 minute cut off function; this is probably one of my least favourite functions and it would be better if this could be switched on and off, as I found that I often had to pump for at least 30 minutes to get my desired output meaning I had to frequently had to turn it back on which was a little frustrating.

However, the pump does remember what setting you were using prior to shutting off so it’s very quick to resume the pumping so it isn’t the end of the world.

The pump can be used discreetly and is relatively quiet, fitting nicely into your bra.

The battery life is good and allows you to get multiple pumps out of a single charge.

One of the worst parts about pumping is the cleaning and sterilizing but the Melia is very compact and easy to clean which makes it even more appealing.

Finally, once you have finished pumping there is a little pouring spot at the top of the shield which is very handy and stops you from spilling any milk.

Overall if you want a pump that is powerful yet comfortable, easy to maintain and most importantly portable and discrete, then I would definitely recommend the Melia.

The pump has changed my perspective on wearable breast pumps as I’ve finally found one that works for me, but it has also changed my whole opinion on pumps in general, due to the quality of Ardo’s products and how comfortable their pump is compared to others I’ve used in the past.

Going forward Ardo will always be my go-to as the whole experience has been such a positive one and I also feel they go the extra mile for the consumer whether that be via email, phone calls or even through there wide range of video resources on their website.

Looking at the cost I feel the pumps are very affordable considering the high standard you are getting and even replacement parts/ accessories are very affordable compared to other brands on the market.

Thank you again Ardo for this amazing experience and for making my breastfeeding and pumping journey this time around a better one.

Continue Reading
2 Comments

2 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Pregnancy

Early birth safer in high blood pressure pregnancies – study

Published

on

Early birth may cut serious complications and stillbirth risk in high blood pressure pregnancies without increasing caesarean rates, a Cochrane review suggests.

Planned early birth after 34 weeks cut serious maternal complications by nearly half compared with watchful waiting, the findings suggest.

It also likely reduced the risk of stillbirth by about 75 per cent, although the authors said this should be interpreted with caution.

Catherine Cluver, senior author of the review and researcher at Stellenbosch University and Tygerberg Hospital, said: “These findings give clinicians and women clearer guidance about the timing of birth when high blood pressure develops in pregnancy.

“For women with pre-eclampsia in particular, the evidence supports offering planned early birth from 34 weeks, and no later than 37 weeks.”

This Cochrane review, led by King’s College London, pooled data from six randomised controlled trials involving 3,491 women.

The trials compared planned early birth after 34 weeks with watchful waiting in women with one or more hypertensive disorders of pregnancy.

Hypertensive disorders of pregnancy, including pre-eclampsia, gestational hypertension and chronic hypertension, are the second leading cause of maternal death globally.

For women with pre-eclampsia, early birth remains the only definitive treatment, as the condition is driven by the placenta and will only resolve once it is delivered.

The trials took place in the Netherlands, UK, US, India and Zambia.

The review found high-certainty evidence that serious maternal complications were nearly halved in women who had planned early birth compared with those managed with watchful waiting.

The finding on stillbirth was based on moderate-certainty evidence and was driven by a single trial in India and Zambia, where stillbirth rates are higher. No stillbirths were recorded in the high-income country trials.

The review also found that planned early birth likely does not increase neonatal unit admission, although this finding was also based on moderate-certainty evidence.

The authors said the maternal benefit held across both high- and low-income settings, suggesting early birth reduces complications even when women are already receiving appropriate monitoring and care.

Alice Beardmore-Gray, lead author of the review and obstetrician at King’s College London, said: “Judging when to offer birth is the question that we battle with clinically every day.”

The authors added that in two of the trials, more than half the women allocated to watchful waiting ended up needing emergency birth before 37 weeks.

They typically gave birth just three to five days later than women allocated to planned early birth and often experienced more complications.

Beardmore-Gray said: “A common misconception is that by waiting longer, mum and baby are gaining more time, but often what you are doing is just delaying an inevitable emergency birth, when both may be in a worse condition.”

The review found high-certainty evidence of no increased risk of caesarean section associated with planned early birth.

Beardmore-Gray said: “That is the first question anyone asks when you offer them an early induction: won’t it increase my risk of a C-section?

“Being able to clearly answer no is a really important piece of information to give women when counselling them about the timing of their birth.”

The authors said the timing of birth should take into account the woman’s preferences and the severity of her condition.

They said these findings are consistent with and reinforce current international guidelines, which recommend that all women with pre-eclampsia should be offered planned early birth no later than 37 weeks.

Women with gestational hypertension or chronic hypertension without severe features may choose to continue with careful monitoring, with planned early birth considered from 39 weeks onwards.

Further research is needed on longer-term outcomes for infants born late preterm and on the long-term cardiovascular health of mothers affected by hypertensive disorders of pregnancy.

Continue Reading

Motherhood

Women’s HealthX marks World Maternal Mental Health Day with lineup of maternity care leaders

Published

on

By Women’s HealthX

In recognition of World Maternal Mental Health Day, Women’s HealthX is placing a spotlight on one of the most urgent and under addressed areas in women’s health: maternal mental health and maternity care innovation.

Worldwide, 1 in 5 new mothers experiences a perinatal mood and anxiety disorder, yet up to 7 in 10 hide or downplay their symptoms.

Even within established care frameworks, this creates challenges for timely detection and treatment, highlighting the need for additional tools, insights, and system-level support to prevent long-term consequences for both mother and child.

Women’s HealthX convenes 750+ senior leaders from across the women’s health ecosystem, including pharma & biotech, hospitals, digital health innovators, solution providers, payers, enterprises & policy makers to explore how telehealth, predictive analytics, and digital health platforms are transforming maternal and postnatal care – from AI-driven early risk identification to remote monitoring solutions that keep mothers cognitively and emotionally supported long after they leave the clinic.

Key sessions on Maternity & Maternal Care with key industry leaders:

Key sessions dedicated to maternity and maternal mental health will address critical system challenges and opportunities for innovation, including fragmentation in care delivery, health inequities, and persistent maternal mortality rates in high income countries.

Featured speakers include:

Christina Pardo, medical director, women’s health, Weill Cornell Medicine NewYork Presbyterian, on “Bridge Existing Healthcare Gaps Caused by Fragmentation Between OB/GYN And Birth Workers.”

Gayatri Setia, director of preventive Cardiology, NYCHHC, on “Improve Patient Access to Prevention in Equalities and Discrimination in Maternity and Maternal Care”

Catherine Monk, founding director, Center for the Transition to Parenthood, Columbia University Irving Medical Center, on “Leveraging Developmental Neuroscience to Provide Improved Maternal Care”

Danielle Johnson, chief medical officer, Lindner Center of HOPE, on “Understanding the Scope of Disparities in Perinatal Mental Health”

Kimberley Sampson, chair of OB GYN, Southwestern Vermont Medical Center, on “Why Maternal Mortality Persists in High-Income Countries”

Erica Smith, VP value and access, Chiesi, on “Empowering Mothers, Advancing Equity, and Improving Outcomes in Premature Care”

A Call to Action for the Femtech Ecosystem

As femtech continues to mature, maternal mental health represents a critical frontier where technology, data, and clinical insight must converge.

Women’s HealthX provides a platform for collaboration and knowledge sharing to accelerate the development and adoption of solutions that deliver measurable impact for mothers and families.

From predictive analytics to personalized, continuous care models, the event underscores a central theme: meaningful transformation in women’s health begins with better data, stronger evidence, and cross sector collaboration.

Special Limited Time Offer

Only 9 days left to register for your chance to win a therapeutic massage at Encore Boston

Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.

Register your Place Now

About Women’s HealthX

Women’s HealthX is where the transformation of women’s health begins at its true foundation: data, science, and evidence.

It’s the leading event dedicated to closing the sex difference data gap and accelerating breakthroughs through science driven, real world case studies.

Taking place on December 3 to 4, 2026 in Boston, USA, the exhibition will bring together more than 750 healthcare leaders, including clinicians, payers, employers, investors, and policymakers.

7 different stages across 2 days with 150+ expert speakers taking an holistic approach to women’s health.

From fertility, maternity, sexual health, cognitive health, menopause and chronic disease, we address care at every stage of a woman’s life.

Continue Reading

Mental health

What Maternal Mental Health Month reveals about where postpartum support actually breaks down

Published

on

By Morgan Rose, chief science officer at Ema, and Lauren Scocozza, vice president of product at Willow

May is Maternal Mental Health Month, and every year it surfaces a familiar set of statistics: 1 in 5 new mothers experiences postpartum depression or anxiety, most go unscreened, and the majority who are screened don’t receive adequate follow-up care.

The conversation is important. But the numbers obscure something that anyone who has worked in this space knows to be true: postpartum mental health distress rarely arrives with a label.

It arrives as exhaustion. As “I’m not sure I’m doing this right.”

As a question about supply, pumping, whether it’s okay to feel this disconnected from something you were supposed to love immediately.

Willow integrated Ema, AI built for women’s health, with the goal of closing the maternal care and data gap.

The pattern mentioned above appears consistently in Ema’s conversational data through the Willow app.

A mother reports mastitis symptoms.

Ema walks her through the clinical presentation, confirms she should keep pumping, and then she questions if she is using her pump correctly. In the same thread, within a few exchanges, she says she’s “feeling too sad.” Then: “I don’t know. I think I’m depressed. I am not enjoying my postpartum.”

She did not come to the app to talk about her mental health.

She came about a breast infection. The mental health disclosure came through the already-opened door.

The Weight Underneath the Technical Question

New motherhood involves an enormous amount of problem-solving at a time when cognitive and emotional reserves are depleted. The pump has to work. The baby has to eat. The body has to recover.

Work comes back. Sleep doesn’t. Feeding their babies requires skill, and the learning curve sits atop it all.

What Ema’s conversation data shows is that the emotional load of navigating these challenges is not separate from mental health. It is mental health.

When a mother writes, “I’m postpartum and overwhelmed and tired,” and then, in the same breath, asks about flange sizing, she is telling us what the postpartum experience actually feels like from the inside.

The technical question and the emotional state are one and the same.

Breastfeeding carries particular weight here.

The desire to breastfeed, the guilt when it doesn’t go as planned, and the identity questions that come with feeding choices are not peripheral to the postpartum mental health conversation.

In our conversations, women navigating supply concerns often reveal deeper anxieties: about whether they are good mothers, whether their bodies are “working,” and whether the difficulty they are experiencing means something about them.

These are the signals worth asking about.

What Screening Looks Like in Practice

Ema is trained on the Edinburgh Postnatal Depression Scale and is equipped to offer the EPDS when a conversation warrants it.

The value is being present for the moment when a woman is ready to name what she’s feeling.

That moment rarely comes as a direct request for mental health support. It comes when someone is already in a conversation about something else, and something shifts.

A woman dealing with mastitis says she feels sad. A woman worried about supply says she doesn’t feel like herself. A woman managing the logistics of going back to work with a wearable pump says she’s not sure she can keep up with it all — and the “it all” isn’t about the pump.

Ema is designed to hear that. She doesn’t stay on the clinical or technical track when the conversation moves. She follows the person.

And when the moment is right, she offers the screening as a natural next step.

In one exchange, a woman was offered the EPDS after disclosing depressive feelings. She declined.

Ema acknowledged that and asked if she wanted to talk about something else. That’s the right response. The offer was made without pressure. The door stays open.

Sometimes what matters most is that someone asked at all.

The Continuity Problem

One of the most persistent structural failures in maternal mental health care is fragmentation.

A woman sees her OB at six weeks postpartum for a brief screening. She may get a call from a nurse. She may be given a referral she never follows up on because she doesn’t have the capacity to navigate a new care relationship while managing a newborn.

The clinical touchpoints are too few, too far apart, and too often siloed from one another.

The postpartum period lasts far longer than the six-week checkup implies. Mental health symptoms can emerge weeks or months after delivery, shift in character over time, and interact with physical challenges in ways that don’t fit neatly into any single provider’s lane.

A lactation concern becomes an anxiety spiral. A supply drop triggers a grief response. A difficult return to work surfaces a postpartum depression that wasn’t fully recognized at six weeks.

Ema sits inside these moments because she’s embedded in the platform women are already using. She doesn’t require a separate appointment, a referral, or the cognitive bandwidth to seek out a new resource.

She’s in the Willow app that mom is already using multiple times a day to manage her pump.

When Ema identifies a woman who may need more support than she can provide, she routes to the right resource — whether that’s a SimpliFed lactation consultant for feeding-related concerns or a clinical professional for mental health follow-up.

The conversation leads to the handoff with someone who can do more.

What the Month of May Means for the Rest of the Year

Maternal Mental Health Month is a useful moment of attention. The awareness campaigns, the social media posts, and the statistics shared in newsletters matter.

But the gap in postpartum mental health care is not really an awareness problem.

Most people in the perinatal space and beyond know the statistics. The problem is access, timing, and continuity.

AI doesn’t close that gap on its own.

What it can do is be present in the spaces where women already are, at the times when they need something, and attentive enough to recognise that a conversation about a pump, a clogged duct, or a supply concern is also a conversation about how someone is doing.

The question behind the question is often the more important one.

For Willow, the conversation data Ema generates is a map of where mothers are struggling, what they reach for when they need help, and when they are ready to say more than they came to say.

That information, used well, shapes better resources, better onboarding, and a more connected experience across the full arc of the postpartum year and beyond.

Building the infrastructure to support maternal mental health is a year-round project.

Willow is doing one part of that, and the conversations happening on the Willow platform every day are evidence that women want support that meets them where they are… in their app, in their moment, without having to ask for it twice.

About the authors

Morgan Rose is Chief Science Officer at Ema, an AI platform for women’s health. Ema partners with healthcare organisations and femtech companies to deliver clinically grounded AI support across the perinatal journey.

Lauren Scocozza is the Vice President of Product at Willow Innovations, Inc. For women by women, Willow is building a maternal care platform to address the interconnected challenges of postpartum.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.